{
    "other_tests": [
        {
            "procedure_name": "Pituitary Surgery",
            "date": "1997",
            "findings": "Partial removal of a 10-mm pituitary adenoma.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Somatostatin analog therapy (Octreotide LAR)",
            "date": "Not specified",
            "findings": "Initially treated with 20 mg every 28 days for 6 months, then increased to 30 mg; no reduction in GH or IGF-I levels and no tumor shrinkage observed.",
            "changes_over_time": "No modifications of GH and IGF-I levels during treatment, and after 6 months, no shrinkage of the tumor remnant was observed."
        },
        {
            "procedure_name": "Cabergoline Treatment",
            "date": "Not specified",
            "findings": "Cleared reduction of GH and IGF-I levels.",
            "changes_over_time": "Reduction of GH and IGF-I levels after 6 months at the dose of 3 mg/week."
        },
        {
            "procedure_name": "Hormonal Determinations",
            "date": "Not specified",
            "findings": "No changes in serum insulin concentrations during treatment.",
            "changes_over_time": "Serum insulin levels were 5196 /H9262 U/min pre-therapy and 4743 /H9262 U/min during therapy."
        }
    ]
}